Primary anti-phospholipid antibody syndrome caused by isolated anti-phosphatidylethanolamine antibodies presenting as cryptogenic fibrosing alveolitis with recurrent pulmonary hemorrhage after single-lung transplantation

Journal of Heart and Lung Transplantation

Volumn 21, Issue 11, 2002, Pages 1232-1236

  Magro, Cynthia M ^a,c   Pope Harman, Amy ^a   Moh, Patrick ^a   Ross, Patrick ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b Cambridge Biomedical Research Group   (United States)

^c THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPID ANTIBODY; PREDNISONE;

ADULT; ALLOGRAFT; ANTIBODY ISOLATION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CAPILLARITIS; CAPILLARY LEAK SYNDROME; CASE REPORT; DISEASE COURSE; DYSPNEA; FIBROSING ALVEOLITIS; HISTOPATHOLOGY; HUMAN; INTERSTITIAL PNEUMONIA; LUNG HEMORRHAGE; LUNG PARENCHYMA; LUNG TRANSPLANTATION; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; RECURRENT DISEASE; SUPPLEMENTATION; THORAX RADIOGRAPHY; THROMBOEMBOLISM;

ADULT; ANTIBODIES; ANTIPHOSPHOLIPID SYNDROME; ENDOTHELIUM, VASCULAR; HEMORRHAGE; HUMANS; LUNG; LUNG DISEASES, INTERSTITIAL; LUNG TRANSPLANTATION; MALE; PHOSPHATIDYLETHANOLAMINES; PULMONARY FIBROSIS;

EID: 0036845790     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(02)00424-2     Document Type: Article

References (22)

1. Kaiser L.R., Cooper J.D. The current status of lung transplantation. Adv Surg. 25:1992;259.
2. Montefusco C.M., Veith F.J. Lung transplantation. Flye M.W., Principles of organ transplantation. 1989;413 WB Sanders, Philadelphia.
3. Piette J.C. Towards improved criteria for the antiphospholipid syndrome. Lupus. 7:1998;S149-157.
4. Hellan M., Kuhnel E., Speiser W., et al. Familial lupus anticoagulant: a case report and review of the literature. Blood Coagul Fibrinolysis. 9:1998;195-200.
5. Katzenstein A.L.A., Fiorelli R.F. Nonspecific interstitial pneumonia/fibrosis histologic features and clinical significance. Am J Surg Pathol. 18:1994;136-147.
6. Kelion A.D., Cockcroft J.R., Ritter J.M. Antiphospholipid syndrome in a patient with rapidly progressive fibrosing alveolitis. Postgrad Med J. 71:1995;233-235.
7. Savin H., Huberman M., Kott E., et al. Fibrosing alveolitis associated with primary antiphospholipid syndrome. Br J Rheumatol. 33:1994;977-980.
8. Tamura A., Matsubara O., Akagawa S., et al. Serum 7S collagen levels in diffuse interstitial lung diseases - index of the destruction of alveolar structure. Nihon Kyobu Shikkan Gakkai Sasshi. 12:1992;2089-2097.
9. Buschman D.L., Ballard R. Progressive massive fibrosis associated with idiopathic pulmonary hemosiderosis. Chest. 104:1993;293-295.
10. Court E.L. Lupus anticoagulants pathogenesis and laboratory diagnosis . Br J Biomed Sci. 54:1997;287-298.
11. Sanmarco M., Alessi M.C., Harle J.R., et al. Antibodies to phosphatidylethanolamine as the only antiphospholipid antibodies found in patients with unexplained thromboses. Thromb Haemost. 85:2001;800-805.
12. Asherson R.A., Cervera R. Review antiphospholipid antibodies and the lung . J Rheumatol. 22:1995;62-66.
13. Huang D.F., Tsai S.T., Wang S.R. Recovery of both acute massive pulmonary hemorrhage and acute renal failure in a systemic lupus erythematosus patient with lupus anticoagulant by the combined therapy of plasmapheresis plus cyclophosphamide. Transfus Sci. 15:1994;283-288.
14. Cohen M.G., Lui S.F. Multiple complications of the antiphospholipid syndrome with apparent response to aspirin therapy. J Rheumatol. 19:1992;803-806.
15. Badesch D., Zamora M., Fullerton D., et al. Pulmonary capillaritis a possible histologic form of acute pulmonary allograft rejection . J Heart Lung Transplant. 17:1998;415-422.
16. Sokel D.K., McIntyre J.A., Short R.A. Henoch-Schönlein purpura and stroke antiphosphatidylethanolamine antibody in CSF and serum . Neurology. 55:2000;1379-1381.
17. Liozon E., Roblot P., Paire D., et al. Anticardiolipin antibody levels predict flares and relapses in patients with giant-cell (temporal) arteritis. A longitudinal study of 58 biopsy-proven cases. Rheumatology. 39:2000;1089-1094.
18. Baleva M., Boyanovsky B., Nikolov K. High levels of IgA anticardiolipin antibodies in patients with systemic lupus erythematosus, Henoch-Schönlein purpura, Sneddon's syndrome, and recurrent pregnancy loss. Thromb Haemost. 82:1999;1774-1775.
19. Hansen K.E., Moore K.D., Ortel T.L., Allen N.B. Antiphospholipid antibodies in patients with Wegener's granulomatosis and polyarteritis nodosa. Arthritis Rheum. 42:1999;2250-2252.
20. Kissel J.T., Halterman R.K., Rammohan K.W., Mendell J.R. The relationship of complement-mediated microangiopathy to the histologic features and clinical duration of disease in dermatomyositis. Arch Neurol. 48:1991;26-30.
21. Crowson A.N., Magro C.M. The role of microvascular injury in the pathogenesis of cutaneous lesions of dermatomyositis. Hum Pathol. 27:1996;15-19.
22. Rauch J., Subang R., D'Agnillo P., et al. Apoptosis and the antiphospholipid syndrome. J Autoimmun. 15:2000;231-235.